Physicians & Healthcare Execs Support mHealth Apps
Electronic Health Records (EHR) vendor, eClinicalWorks has released a report that indicates physicians are by-and-large supportive of mHealth applications. Mobile health apps have been growing in popularity with patients in recent months, helping them schedule appointments, email nurses, and receive follow up reminders and access personal EHR data, however the new report indicated that medical professionals are also embracing the new technology.
The report polled 650 physicians and the overwhelming majority (93 percent) felt that mHealth apps had the potential to improve patient care. A similar percentage also thought that it would be beneficial to give patients the ability to upload data into their personal EHR file. Furthermore 89 percent of physicians polled said they would recommend apps to patients in the future.
The following mHealth capabilities were cited by physicians as the most beneficial >>>
- The ability to send reminders and alerts to patients
- The ability to allow patients’ access to their own PHI from mobile devices
- The ability to conduct administrative tasks like appointment scheduling
- The ability to receive more accurate self-reported data from patients on a regular basis
Preventative care, diabetes monitoring, weight management, and medication adherence were all areas of opportunity for mHealth apps to address.
The mHealth market is constantly developing, and is expected to reach 1.7 billion users worldwide by 2017 - it is also expected to be worth an astonishing $26 billion. It is believed that patients and physicians are beginning to trust apps a lot more, and regulators such as Happtique are working to develop that level of trust. The new report by eClinicalWorks also highlights that physicians and healthcare executives are also beginning to see the benefit, not only in terms of patient care, but also in terms of finance and efficiency. mHealth apps can be used in many ways including diagnosis, monitoring and treatment.
Read Related Articles On Healthcare Global
- Happtique Announces Medical App Certification
- Microsoft Surface Enters The mHealth Market
- Medical Devices Changing Doctor/Patient Communication
- mHealth: Changing Doctor / Patient Care
- Mobile Technology Restrenghthens The Health Industry
Mobile health apps are projected to save more than $500 billion in productivity, travel and administrative costs over the next 10 years, meaning that consumers, physicians and healthcare executives should sit in and take notice.
“In order to transform healthcare, patients need to be engaged,” said Girish Kumar Navani, CEO and Co-Founder of eClinicalWorks. “People are invested in and want to be engaged in their health as long as they trust the source of the information.”
Mobile apps are leading the way in many industries across the globe – the emphasis on mobile connectivity is huge, and never more has this been truer for healthcare provision. mHealth applications have huge scope and potential, not only in the developed world but also in emerging continents.
Introducing Dosis - the AI powered dosing platform
Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works.
When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing.
The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced.
What is the Strategic Anemia Advisor?
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease.
SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool.
What else is Dosis working on?
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs.
What are Dosis' strategic goals for the next 2-3 years?
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.
What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.